Drug Shortage Report for AURO-MONTELUKAST

Last updated on 2024-02-13 History
Report ID 219302
Drug Identification Number 02401274
Brand name AURO-MONTELUKAST
Common or Proper name AURO-MONTELUKAST
Company Name AURO PHARMA INC
Market Status MARKETED
Active Ingredient(s) MONTELUKAST
Strength(s) 10MG
Dosage form(s) TABLET
Route of administration ORAL ORAL
Packaging size 90's
ATC code R03DC
ATC description OTHER SYSTEMIC DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES
Reason for shortage Demand increase for the drug.
Anticipated start date
Actual start date 2024-02-12
Estimated end date 2024-02-29
Actual end date
Shortage status Actual shortage
Updated date 2024-02-13
Company comments
Health Canada comments
Tier 3 Status No
Contact Address 3700 STEELES AVENUE WEST, SUITE 402
WOODBRIDGE, ONTARIO
CANADA L4L 8K8
Company contact information Balaji Srinivasan

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v3 2024-02-13 English Compare
v2 2024-02-12 French Compare
v1 2024-02-12 English Compare

Showing 1 to 3 of 3